Introduction
============

*Wuchereria bancrofti* vectored by mosquitoes is a human parasitic filarial round worm responsible for the disease-lymphatic filariasis (LF) ([@R1]). Of note, is the fact that *Wucheriria bancrofti* is more prevalent than filariasis from *Brugia malayi* and *Brugia timori*, as infection could advance to a chronic stage like elephantiasis of the extremities and genitals ([@R1]).

In sub-Saharan Africa, 512 million people are at risk of being infected, while 28 million are known to be infected ([@R2]). Although mortality from LF is low, the disease is the fourth leading cause of Disability Adjusted Life Years (DALYs) ([@R2],[@R3]).

Nigeria is ranked the third most endemic country globally; and in the past, studies on the disease distribution were classified based on the disease prevalence at national or sub-national levels with no account for geopolitical zones heterogeneity ([@R4]). Therefore, such estimates did not accurately capture LF burden at zonal levels ([@R5]). Analyzing data at geopolitical/zonal level would provide more detailed report on the dynamics of the disease in a way that the disease prevalence and burden could be mapped and as such guide on control strategy. This review article thus presents prevalence data of LF from endemic areas in Nigeria and highlights the gaps in knowledge.

Case Details
============

LF, after malaria happens to be the second most common vector-borne parasitic diseases; and it is present in over 80 tropical and subtropical countries ([@R6]). According to WHO, LF ranks second as the common cause of long-term disability after mental illness ([@R6],[@R7]). LF is of global recognition, playing a significant role in the overall Africa disease burden. Furthermore, one-third of infected persons live in India, a third live in Africa and the remainder in the Americas, the Pacific Island, Papua New Guinea and South-East Asia ([@R8]). Persons with LF and other helminthic diseases particularly women and children become more susceptible to secondary infection with HIV/AIDS, tuberculosis and malaria ([@R2]). LF is known to cause a wide range of clinical and subclinical symptoms. It is estimated that two-thirds of infected individuals present no obvious proof of the disease, but when tested, they showed some level of immunosuppression. In addition, there could be evidence of renal dysfunction, chronic lymphoedema, elephantiasis and hydrocele.

Evidence of debilitating effect of acute filarial attacks that have been said to last from five to seven days and may occur two to three times each year have been associated with sufferers of LF ([@R6],[@R7]). Chronic filarial disease appears to correlate with serious social and economic burden as those afflicted with elephantiasis and hydrocele are often socially marginalized and are poor based on the severity of disease ([@R9]). Episodes of acute attack and chronic disability reduce economic output and increase poverty ([@R6]). Due to stigmatization, affected individuals avoid seeking treatment, and this result in the reoccurrence of acute febrile attacks and subsequent damage to the lymphatic system ([@R9],[@R10]). Infected women bear double burden as young unmarried women could be forced to live a secluded life and thus limit the prospect of marriage.

More so, recurrent debilitating acute episodes hinder their ability to be gainfully employed. Consequently, the cost of health care as well as other needs make them financially dependent on other people ([@R11],[@R12]). In West Africa and Thailand, there is a general believe that children born to women affected by LF would bear similar disease burden ([@R2],[@R13]). Shame and fear are associated with difficulties in conceiving, and these feelings are peculiar to LF patients globally ([@R14]). Meanwhile, women may have concerns about marrying men with physical sign of LF; their gender expectation and prevailing power strata often leave them in hopeless situations. In Haiti and Ghana, researchers alluded to the point that the risk of unhappiness and marriage breakdown was greater in marriages where the wife had physical signs of filariasis ([@R11],[@R15]).

In Nigeria, LF is widespread and it is a serious public health problem ([@R1]). Of the 36 states, LF studies were available for nineteen states ([@R19]) ([Table 1](#T1){ref-type="table"}). These studies spanned through the different geo-political zones (North-West, North-East, North-Central, South-West, South-East and South-South) of the country., However, there is still limited/lack of literature on the prevalence of LF disease in some other states.

###### 

Prevalence of Lymphatic filariasis across Zones and State

  ------------------------------------------------------------------------------------------------------------
  Zones        States        Sample\   Diagnostic\            Prevalence\   Study population      Reference
                             size      techniques             (%)                                 
  ------------ ------------- --------- ---------------------- ------------- --------------------- ------------
  North-West   Kano          2790      Blood smear            1.7           Men and Women         \[[@R21]\]

               Kano          357       Blood smear            3.6           Indigens of Kano      \[[@R41]\]

               Kano          54943     Hydrocelectomy         2.31          Indigens of Kano      \[[@R42]\]

               Kaduna        793       cases                  7.4           Indigens of Kaduna    \[[@R43]\]

               Kaduna        341       DEC provocation        2.9           Men and Women         \[[@R44]\]

               Zamfara       501       ICT Card test\         38.7          Men and Women         \[[@R22]\]
                                       RDT kit                                                    

  North-East   Bauchi        1628      Incubation             1.4           Men and Women         \[[@R45]\]

               Taraba        336       ICT Card test          30.05         Indigens of Taraba    \[[@R46]\]

               Taraba        458       Blood smear            33.84         Men and Women         \[[@R47]\]

               Taraba        327       Blood smear            30.8          Indigens of Taraba    \[[@R48]\]

               Taraba        1031      Blood smear            21.2          Children and Adults   \[[@R49]\]

  North-       Benue         248       ICT Card test          32.6          Indigens of Benue     \[[@R50]\]

  Central      Kogi          1069      ICT Card test          3.4           Male and Female       \[[@R51]\]

               Plateau       7250      Clinical examination   0.4           Men and Women         \[[@R52]\]

               Plateau       940       Blood smear            1.8           Men and Women         \[[@R53]\]

  South-West   Ogun          500       Blood smear            21.0          Children and Adults   \[[@R54]\]

               Ogun          317       Blood smear            17            Children and Adults   \[[@R55]\]

               Ogun          587       Blood smear            3.2           Children and Adults   \[[@R56]\]

               Ondo          231       ICT Card test          29            Adolescent            \[[@R57]\]

               Ondo          1090      ICT Card test          27            Children and Adults   \[[@R58]\]

               Osun          870       ICT Card test          1.7           Children and Adults   \[[@R59]\]

               Oyo           95        Physical examination   26.3          Indigens of Oyo       \[[@R60]\]

  South-East   Abia          498       Blood smear            22.3          Indigens of Abia      \[[@R61]\]

               Ebonyi        1243      Blood smear            16.9          Children and Adults   \[[@R1]\]

               Ebonyi        600       ICT Card test          23.50         Indigens of Ebonyi    \[[@R62]\]

               Ebonyi        425       Clinical examination   8.23          Men and Women         \[[@R63]\]

               Imo           200       Blood smear            20            Men and Women         \[[@R64]\]

               Imo           845       Blood smear            8.9           Children and Adults   \[[@R65]\]

  South-       Akwa-Ibom     400       Concentration          3.5           Children and Adults   \[[@R66]\]

  South        Bayelsa       78        Concentration          10.5          Children and Adults   \[[@R67]\]

               Cross-River   897       Blood smear            15.5          Children and Adults   \[[@R68]\]

               Cross-River   785       Blood smear            6.1           Children and Adults   \[[@R69]\]

               Cross-River   829       Blood smear            5.5           Children and Adults   \[[@R70]\]

               Rivers        1351      Blood smear            3.3           Children and Adults   \[[@R18]\]
  ------------------------------------------------------------------------------------------------------------

DEC: diethylcarbamazine; ICT: immunochromatographic test; RDT: Rapid diagnostic test.

Cases of high prevalence of LF due to *Wuchereria bancrofti* have been reported with infection rates ranging between 9.1% and 18.8% in the eastern region and northern region respectively ([@R16]). Mbah and Njoku ([@R17]) reported a prevalence rate of 18.8% in Anambra State. Udonosi ([@R18]) observed prevalence rates of 8.7%, 11.8% and 14.9--25.6% in Imo and Rivers States respectively. Co-endemicity of *Wuchereria bancrofti, Loa loa, Onchercerca volvulus* with *Mansonella perstans* had a prevalence rate of 21.21% in Rivers and Bayelsa States ([@R18]). Furthermore, Braide et al ([@R19]) reported 13 cases of LF in Cross Rivers State. Amadi and Udonosi ([@R20]) also reported a prevalence rate of 4.4% in Ogoniland, Rivers State. Recently, Dogara et al ([@R21]a) reported a prevalence rate of 30.2% in Kano. More recently, Ladan et al ([@R22]) in his studies on the seroprevalence of LF in six communities of Bungudu Local Government Area of Zamfara State reported a prevalence rate of 38.72%. The prevalence data in North-East, North-West and South-West is largely unknown ([Figure 1](#F1){ref-type="fig"}).
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LF has impacted negatively on marriage and sexual life in endemic areas. Stigmatization of men with hydrocoele is also observed in some of the endemic countries as villagers in some parts of Nigeria discontinues association from people with filarial skin lesions and men with genital complications and elephantiasis ([@R3]). Furthermore, of the 128 million people estimated to be infected worldwide ([@R11],[@R23],[@R24]), 22 million (17.2%) are children (school-aged) below the age of 15. LF ranks the second leading cause of long-term disability ([@R7]). More so, it has been linked with serious impairment of mobility ([@R25]), affecting school-aged children\'s education and future career prospects due to regular absenteeism from school ([@R26]). The affected children become frustrated to the point that they abandon their education and future endeavors ([@R27]).

Poor response of victims to submit themselves for examination and refusal to give night blood samples are challenges against the effective study of LF in Nigeria ([@R20]). Environmental factors and conditions influencing LF transmission are similar to those existing elsewhere in the tropics and other sub-Saharan African countries. Factors such as rural to urban migration, increasing urbanization, inadequate waste disposal and deteriorating sanitary conditions in the country could increase the number of breeding sites for the mosquito vectors ([@R28]). The roles of mosquitoes and other dipterans in transmitting the parasitic agents of filariasis are poorly acknowledged in many endemic communities. Therefore, it is surprising that there is little awareness on the need to minimize mosquito contact. Vectors like *Culex papiens quinquefasciatus* are distributed across the tropics and warm temperate regions and are believed to be indigenous to the low lands of West Africa. These vectors have reached the new world through slave ships; meanwhile an alternate hypothesis suggest it originates in Southeast Asia ([@R29]). *Culex papiens quinquefasciatus* are found in association with other mosquitoes\' species in domestic and peri domestic water containers ([@R30]). Breeding takes place in eutrophic water of artificial containers or man-made impoundments like ditches, ponds, drains with high nutrient containing human or animal sewage ([@R30]). Factors such as adequate rainfall and longevity of the female *C.p. quinquefasciastus* have been attributed to survival and reproduction. With distinct rainy season, their population reaches its peak densities during or immediately after the rainy season, while in subtropical and warm temperate areas, peak populations occur during the warmest month of the year ([@R30]). *Stomoxys* species is a filth fly with worldwide medical and veterinary importance. There are 18 known species in the genus *Stomoxys*. *Stomoxys calcitran* is the only species that is synanthropic and present worldwide. *Stomoxys* species breeds in moist, decaying organic matter, while suitable environmental conditions like temperature of 27°C, availability of host for blood meal, influence their survival and reproduction ([@R31]). Some of these associated agents that contribute to spread of the disease increase the disease burden, and hence, impacting positively on the spread of the disease.

There are many diagnostic methods available for the detection of LF. Until the 1980s, the only direct method to ascertain a diagnosis of infection by *W. bancrofti* was via the identification of microfilariae (MF) in the peripheral blood using camera counting, polycarbonate membrane filtration, the thick smear method or Knott\'s technique ([@R32]). Meanwhile, apart from their relatively low sensitivities, these methods only identify filarial infection by way of microfilaremia.

In the 1990s, significant improvements were made in the diagnosis of LF with the emergence of new diagnostic tools; namely, use of recombinant antigens to detect specific antibodies ([@R33]), PCR for the detection of filarial DNA, the visualization of live adult worms (AW) using ultrasound (US) and circulating filarial antigen (CFA) detection ([@R34]). Presently, the standard diagnostic tools are US ([@R34]) and CFA detection technique, with the latter using the monoclonal antibodies (McAbs) Og4C3 and AD12. Meanwhile, the CFA detection techniques are commercially available in the form of kits with the advantage of ensuring the possibility of diagnosis using blood samples collected at any time of the day ([@R34],[@R35]). However, in Nigeria, there is no report of the use of molecular diagnostic tools for LF infection; therefore, we believe that the prevalence estimates presented in this report is significantly underestimated.

Discussion
==========

In drafting a cost-effective control for diseases, it is paramount that the disease burden be estimated. Disability Adjusted Life Year (DALYs) has become fast increasing metric measurement to assess disease burden ([@R36]). DALYs include years of life lost due to mortality (YLLs) and years lived with disability (YLDs). Reports of LF infection burden measured in DALYs are unavailable. Here, we have estimated the value of YLD ([Table 2](#T2){ref-type="table"}) based on the available prevalence data and morbidity of the infection ([@R37]). YLD due to LF in this review was estimated using this formula ([@R38]): YLD = P × DW; Where P = number of prevalence cases, DW=Disability Weight.

###### 

*Lymphatic filariasis* mean prevalence and estimated YLD according to geopolitical zones (1982--2018)

  Region          Mean ± SD (%)   YLD per 10 000
  --------------- --------------- ----------------
  North-West      9.4 ± 14.5      44.0
  North-East      23.5 ± 13.3     16.0
  North-Central   9.6 ± 15.4      4.0
  South-West      17.9 ± 11.3     16.0
  South-East      16.6 ± 6.6      17.0
  South-South     7.4 ± 4.7       10.0

Furthermore, prevalence was used rather than incidence ([@R38]), because in Nigeria, surveys are widely reported in prevalence ([Table 1](#T1){ref-type="table"}). However, DW (0.027) of infection which is represented on a scale of 0--1 (0=perfect health; 1=death), was adopted ([@R39]). YLDs due to LF, according to the geo-political zones are shown in [Table 2](#T2){ref-type="table"}. This review shows that the YLD from LF prevalence data in Nigeria ranged from 4.0 to 44.0 with the highest and least disease burdens recorded in North-West and North-Central respectively.

Control and elimination rely largely on chemotherapy through mass drug administration (MDA) to interrupt transmission of infection ([@R40]). Drugs commonly administered against LF in Nigeria are diethylcarbamazine (DEC), Albendazole and ivermectin. Studies based on selective treatment with single dose of DEC (6mg/kg) have been reported to decrease MF by 90% and adult by 50% ([@R40]). Furthermore, vector control methods such as the use of insecticides treated mosquito nets, indoor residual spraying as well as environmental sanitation would reduce the vector population and consequently the transmission of the disease. The YLD data in this report has clearly described the national situation and thus call for the need to intensify surveillance and treatment across all strata. LF control in Nigeria should especially be of high priority in the North-West.

The data in this review have highlighted LF prevalence in Nigeria, with North-West having the highest disease burden. The high prevalence in the North-West is largely attributed to unfavorable climatic conditions that threw up man-made options like construction of irrigation, thereby further enhancing the disease vectors to thrive. It is recommended that LF survey be carried out in states where prevalence data are yet to be available, so that a proper and more comprehensive evaluation of the LF situation in Nigeria be done to the extent that the most effective control strategy can be adopted and applied. Furthermore, to have a near-accurate picture of the prevalence of the disease, a more sensitive diagnostic method should be employed.
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